GRPR and small cell lung carcinoma: Indeed, we postulate that high-affinity binding of antagonist peptides to SCLC cell surface GRPR would be expected to increase the local accumulation of the liposomes in the cell surface, thus increasing the probability of drug accumulation in the target cells, without activating GRPR signalling.